<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11</volume><submitter>La Mantia L</submitter><journal>The Cochrane database of systematic reviews</journal><pagination>CD009333</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6464642</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.</pubmed_title><pmcid>PMC6464642</pmcid><pubmed_authors>Di Pietrantonj C</pubmed_authors><pubmed_authors>Frau S</pubmed_authors><pubmed_authors>Vaona A</pubmed_authors><pubmed_authors>Longobardi A</pubmed_authors><pubmed_authors>Rovaris M</pubmed_authors><pubmed_authors>Berardo F</pubmed_authors><pubmed_authors>Weinstock-Guttman B</pubmed_authors><pubmed_authors>Rigon G</pubmed_authors><pubmed_authors>La Mantia L</pubmed_authors><pubmed_authors>Gandini A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Nov</publication><modification>2025-04-18T18:17:32.041Z</modification><creation>2025-02-18T23:39:31.226Z</creation></dates><accession>S-EPMC6464642</accession><cross_references><pubmed>27880972</pubmed><doi>10.1002/14651858.CD009333.pub3</doi><doi>10.1002/14651858.cd009333.pub3</doi></cross_references></HashMap>